Download PDF
Semin Neurol 2022; 42(06): 758-766
DOI: 10.1055/a-1985-7000
Review Article

Challenging Cases in Cerebrovascular Disease

Michael A. Kelly 
1   Department of Neurology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois
,
Jasmine Singh
2   Department of Neurology, University of California San Diego Ringgold Standard Institution, La Jolla, California
,
Alexandra Balabanov
1   Department of Neurology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois
,
Adam Wadina
1   Department of Neurology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois
,
Braden Dasovic
1   Department of Neurology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Disorders involving the vascular system of the brain are numerous and sundry. Atherosclerotic thromboembolism of large vessels and lacunar infarctions of small vessel disease are well known. Brain infarction due to cardioembolism is common as well, and even more so when diligently sought. Rupture of intracranial blood vessels results in subarachnoid and intraparenchymal hemorrhage. We present four cases of stroke of uncommon cause and remind clinicians to be open minded to the many possible causes of stroke, in particular because early recognition and treatment is often critical. Case 1 discusses a patient with inflammatory cerebral amyloid angiopathy. The presentation, ability to recur, and current treatment considerations are reviewed. Case 2 discusses microangiopathic thrombotic angiopathy. Diagnosis and treatment are considered. An association with interferon therapy and the evolving terminology of this and related conditions are discussed. Case 3 discusses intracranial hemorrhage secondary to acute promyelocytic leukemia. Patients with acute leukemias require aggressive management of their coagulopathy, thrombocytopenia, and the disease itself. Finally, Case 4 discusses ischemic stroke due to a paradoxical embolism in the setting of a patent foramen ovale (PFO). Both medical and surgical management of a PFO for stroke prevention are considered.

Keywords

cerebral amyloid angiopathy - microhemorrhage - thrombotic microangiopathy - interferon therapy - acute promyelocytic leukemia - patent foramen ovale


Publication History

Accepted Manuscript online:
23 November 2022

Article published online:
09 January 2023

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Wu JJ, Yao M, Ni J. Cerebral amyloid angiopathy-related inflammation: current status and future implications. Chin Med J (Engl) 2021; 134 (06) 646-654
    CrossrefPubMedGoogle Scholar
  • 2 Auriel E, Charidimou A, Gurol ME. et al. Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy–related inflammation. JAMA Neurol 2016; 73 (02) 197-202
    CrossrefPubMedGoogle Scholar
  • 3 Renard D, Tatu L, Collombier L. et al. Cerebral amyloid angiopathy and cerebral amyloid angiopathy-related inflammation: comparison of hemorrhagic and DWI MRI features. J Alzheimers Dis 2018; 64 (04) 1113-1121
    CrossrefPubMedGoogle Scholar
  • 4 Crosta F, Orlandi B, De Santis F. et al. Cerebral amyloid angiopathy-related inflammation: report of a case with very difficult therapeutic management. Case Rep Neurol Med 2015; 2015: 483020
    PubMedGoogle Scholar
  • 5 Regenhardt RW, Thon JM, Das AS. et al. Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy–related inflammation. JAMA Neurol 2020; 77 (10) 1261-1269
    CrossrefPubMedGoogle Scholar
  • 6 Antolini L, DiFrancesco JC, Zedde M. et al. Spontaneous ARIA-like events in cerebral amyloid angiopathy-related inflammation: a multicenter prospective longitudinal cohort study. Neurology 2021; 97 (18) e1809-e1822
    CrossrefPubMedGoogle Scholar
  • 7 Goldberg RJ, Nakagawa T, Johnson RJ, Thurman JM. The role of endothelial cell injury in thrombotic microangiopathy. Am J Kidney Dis 2010; 56 (06) 1168-1174
    CrossrefPubMedGoogle Scholar
  • 8 Hofer J, Rosales A, Fischer C, Giner T. Extra-renal manifestations of complement-mediated thrombotic microangiopathies. Front Pediatr 2014; 2: 97
    CrossrefPubMedGoogle Scholar
  • 9 Noorbakhsh-Sabet N, Pulakanti VC, Zand R. Uncommon causes of cerebral microbleeds. J Stroke Cerebrovasc Dis 2017; 26 (10) 2043-2049
    CrossrefPubMedGoogle Scholar
  • 10 Sonneveld MA, de Maat MP, Portegies ML. et al. Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood 2015; 126 (25) 2739-2746
    CrossrefPubMedGoogle Scholar
  • 11 Allinovi M, Cirami CL, Caroti L. et al. Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab. Clin Kidney J 2017; 10 (05) 625-631
    CrossrefPubMedGoogle Scholar
  • 12 Gulleroglu K, Fidan K, Hançer VS, Bayrakci U, Baskin E, Soylemezoglu O. Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab. Pediatr Nephrol 2013; 28 (05) 827-830
    CrossrefPubMedGoogle Scholar
  • 13 Elshazzly ME, Hammo B, Buhtoiarov IN. A case of subacute brain hemorrhage and disseminated intravascular coagulation secondary to acute promyelocytic leukemia in a pediatric patient. Cureus 2021; 13 (05) e14922
    PubMedGoogle Scholar
  • 14 Sanz MA, Montesinos P. Advances in the management of coagulopathy in acute promyelocytic leukemia. Thromb Res 2020; 191 (Suppl 1): S63-S67
    CrossrefPubMedGoogle Scholar
  • 15 Del Prete C, Kim T, Lansigan F, Shatzel J, Friedman H. The epidemiology and clinical associations of stroke in patients with acute myeloid leukemia: a review of 10,972 admissions from the 2012 National Inpatient Sample. Clin Lymphoma Myeloma Leuk 2018; 18 (01) 74-77 .e1
    CrossrefPubMedGoogle Scholar
  • 16 Ferro JM, Infante J. Cerebrovascular manifestations in hematological diseases: an update. J Neurol 2021; 268 (09) 3480-3492
    CrossrefPubMedGoogle Scholar
  • 17 Cornelissen LL, Kreuger AL, Caram-Deelder C. et al. Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia - a nested case-control study. Ann Hematol 2021; 100 (01) 261-271
    CrossrefPubMedGoogle Scholar
  • 18 Hakman EN, Cowling KM. Paradoxical embolism. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2021
    Google Scholar
  • 19 Tobis MJ, Azarbal B. Does patent foramen ovale promote cryptogenic stroke and migraine headache?. Tex Heart Inst J 2005; 32 (03) 362-365
    PubMedGoogle Scholar
  • 20 Kasner SE, Lattanzi S, Fonseca AC, Elgendy AY. Uncertainties and controversies in the management of ischemic stroke and transient ischemic attack patients with patent foramen ovale. Stroke 2021; 52 (12) e806-e819
    CrossrefPubMedGoogle Scholar
  • 21 Elgendy AY, Saver JL, Amin Z. et al. Proposal for the updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke. JAMA Neurol 2020; 77 (07) 878-886
    CrossrefPubMedGoogle Scholar
  • 22 Meacham III RR, Headley AS, Bronze MS, Lewis JB, Rester MM. Impending paradoxical embolism. Arch Intern Med 1998; 158 (05) 438-448
    CrossrefPubMedGoogle Scholar
  • 23 Saremi F, Emmanuel N, Wu PF. et al. Paradoxical embolism: role of imaging in diagnosis and treatment planning. Radiographics 2014; 34 (06) 1571-1592
    CrossrefPubMedGoogle Scholar
  • 24 Ren P, Li K, Lu X, Xie M. Diagnostic value of transthoracic echocardiography for patent foramen ovale: a meta-analysis. Ultrasound Med Biol 2013; 39 (10) 1743-1750
    CrossrefPubMedGoogle Scholar
  • 25 Collado FMS, Poulin MF, Murphy JJ, Jneid H, Kavinsky CJ. Patent foramen ovale closure for stroke prevention and other disorders. J Am Heart Assoc 2018; 7 (12) e007146
    CrossrefPubMedGoogle Scholar
  • 26 Kleindorfer DO, Towfighi A, Chaturvedi S. et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 2021; 52 (07) e364-e467
    CrossrefPubMedGoogle Scholar
  • 27 Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood 2015; 125 (04) 616-618
    CrossrefPubMedGoogle Scholar
  • 28 Reese JA, Bougie DW, Curtis BR. et al. Drug-induced thrombotic microangiopathy: experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol 2015; 90 (05) 406-410
    CrossrefPubMedGoogle Scholar
  • 29 Saleem R, Reese JA, George JN. Drug-induced thrombotic microangiopathy: an updated systematic review, 2014-2018. Am J Hematol 2018; 93 (09) E241-E243
    CrossrefPubMedGoogle Scholar